Accanito Therapeutics
Advises the CEO on clinical development, indication prioritization, and the development roadmap ahead of financing.
Selected advisory interests
I engage selectively with founders, investors, and biotech teams on questions related to translational strategy, portfolio diligence, early company formation, and capital-efficient development planning.
Areas of engagement
Current advisory roles
Advises the CEO on clinical development, indication prioritization, and the development roadmap ahead of financing.
Brings a background in molecular biology, translational development, portfolio strategy, and company formation.
For a focused discussion about a scientific opportunity, portfolio decision, or strategic question.
Get in touch